Novel Coronavirus Pneumonia (COVID-19)
Conditions
Interventions
Experimental group:Routine treatment + plasma treatment
Control group:Routine treatment
Sponsors
The First Affiliated Hospital of Nanchang University
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: 1) The confirmed patient (or legal guardian) agrees to participate in the study and signs the informed consent form; 2) aged 18 to 65 years; 3) Real-time fluorescent RT-PCR of respiratory specimens or blood specimens to detect patients with new type of coronavirus positive; 4) Patients diagnosed as severe and critically ill and with rapid disease progression according to the "Diagnosis and Treatment Program for Pneumonia of New Coronavirus Infection (Trial Version 6)".
Exclusion criteria
Exclusion criteria: 1) Any situation where the solution cannot be carried out safely; 2) Allergic constitution, allergic to plasma or drugs; 3) Being too old with severe underlying diseases that affect survival, including uncontrolled clinically significant heart, lung, kidney, digestive, hematological, neuropsychiatric, immune, metabolic, or malignant tumors, Severe malnutrition, etc.; 4) Patients with severe respiratory failure, heart failure, and multiple organ failure; 5) Participants in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Cure rate;Mortality; | — |
Secondary
| Measure | Time frame |
|---|---|
| Length of stay; | — |
Countries
China
Contacts
Public ContactLe Aiping
The First Affiliated Hospital of Nanchang University
Outcome results
None listed